New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 31, 2012
11:54 EDTNUVANuVasive poised to take share after disc system approval, says Barrington
After NuVasive's PCM cervical disc system was approved by the FDA, Barrington thinks the device leaves the company poised to take share. The firm maintains a $25 target and Outperform rating on the stock.
News For NUVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 26, 2015
12:03 EDTNUVANuVasive CEO news an incremental positive, says Piper Jaffray
Piper Jaffray views NuVasive's naming Greg Lucier as its permanent CEO as an incremental positive despite the executive's lack direct experience in the spine industry. Piper notes its channel checks indicate no meaningful sales force disruption from the CEO transition. It reiterates an Overweight rating on NuVasive with a $56 price target.
10:13 EDTNUVAHigh option volume stocks
High option volume stocks: GFI EAT DSKY CHTR BID ADTN BLMN EXPR YCS NUVA
08:36 EDTNUVANuVasive appoints Gregory Lucier as CEO
Subscribe for More Information
May 14, 2015
13:58 EDTNUVANuVasive initiated with a Market Perform at Northland
Target $46.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use